Literature DB >> 17098208

Frataxin knockdown causes loss of cytoplasmic iron-sulfur cluster functions, redox alterations and induction of heme transcripts.

Chunye Lu1, Gino Cortopassi.   

Abstract

Frataxin protein deficiency causes the neurodegenerative disease Friedreich ataxia. We used inducible siRNA to order the consequences of frataxin deficiency that we and others have previously observed. The earliest consequence of frataxin deficiency was a defect in cytoplasmic iron-sulfur proteins. In the second phase, protein oxidative damage increased, and CuZnSOD was induced, as was the unfolded protein response (UPR), long before any decline in mitochondrial aconitase activity. In the third phase, mitochondrial aconitase activity declined. And in the fourth phase, coincident with the decrease in heme-containing cytochrome c protein, a transcriptional induction of the heme-dependent transcripts ALAS1 and MAOA occurred. These observations suggest that the earliest consequences of frataxin deficiency occur in ISC proteins of the cytoplasm, resulting in oxidative damage and stress and activation of the unfolded protein response which has been associated with neurological disease, and that later consequences involve mitochondrial iron-sulfur cluster deficiency, heme deficiency, and then increased heme biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098208      PMCID: PMC1847786          DOI: 10.1016/j.abb.2006.09.010

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  53 in total

1.  Aripiprazole treatment for psychosis associated with Friedreich's ataxia.

Authors:  Yiu-Chung Chan
Journal:  Gen Hosp Psychiatry       Date:  2005 Sep-Oct       Impact factor: 3.238

Review 2.  Metal-catalyzed oxidation of proteins. Physiological consequences.

Authors:  E R Stadtman; C N Oliver
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

3.  Heightened stress response in primary fibroblasts expressing mutant eIF2B genes from CACH/VWM leukodystrophy patients.

Authors:  Liraz Kantor; Heather P Harding; David Ron; Raphael Schiffmann; Christine R Kaneski; Scot R Kimball; Orna Elroy-Stein
Journal:  Hum Genet       Date:  2005-10-28       Impact factor: 4.132

4.  Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice.

Authors:  René Thierbach; Tim J Schulz; Frank Isken; Anja Voigt; Brun Mietzner; Gunnar Drewes; Jürgen-Christoph von Kleist-Retzow; Rudolf J Wiesner; Mark A Magnuson; Hélène Puccio; Andreas F H Pfeiffer; Pablo Steinberg; Michael Ristow
Journal:  Hum Mol Genet       Date:  2005-11-08       Impact factor: 6.150

5.  A pool of extramitochondrial frataxin that promotes cell survival.

Authors:  Ivano Condò; Natascia Ventura; Florence Malisan; Barbara Tomassini; Roberto Testi
Journal:  J Biol Chem       Date:  2006-04-11       Impact factor: 5.157

6.  Gene expression profiling in frataxin deficient mice: microarray evidence for significant expression changes without detectable neurodegeneration.

Authors:  Giovanni Coppola; Sang-Hyun Choi; Manuela M Santos; Carlos J Miranda; Dmitri Tentler; Eric M Wexler; Massimo Pandolfo; Daniel H Geschwind
Journal:  Neurobiol Dis       Date:  2006-01-25       Impact factor: 5.996

7.  ATF3 expression precedes death of spinal motoneurons in amyotrophic lateral sclerosis-SOD1 transgenic mice and correlates with c-Jun phosphorylation, CHOP expression, somato-dendritic ubiquitination and Golgi fragmentation.

Authors:  Angela S Vlug; Eva Teuling; Elize D Haasdijk; Pim French; Casper C Hoogenraad; Dick Jaarsma
Journal:  Eur J Neurosci       Date:  2005-10       Impact factor: 3.386

8.  Frataxin deficiency alters heme pathway transcripts and decreases mitochondrial heme metabolites in mammalian cells.

Authors:  Robert A Schoenfeld; Eleonora Napoli; Alice Wong; Shan Zhan; Laurence Reutenauer; Dexter Morin; Alan R Buckpitt; Franco Taroni; Bo Lonnerdal; Michael Ristow; Hélène Puccio; Gino A Cortopassi
Journal:  Hum Mol Genet       Date:  2005-10-20       Impact factor: 6.150

9.  Tumor necrosis factor alpha (TNFalpha) induces the unfolded protein response (UPR) in a reactive oxygen species (ROS)-dependent fashion, and the UPR counteracts ROS accumulation by TNFalpha.

Authors:  Xin Xue; Jiang-Hu Piao; Akihito Nakajima; Sachiko Sakon-Komazawa; Yuko Kojima; Kazutoshi Mori; Hideo Yagita; Ko Okumura; Heather Harding; Hiroyasu Nakano
Journal:  J Biol Chem       Date:  2005-08-17       Impact factor: 5.157

10.  Mitochondrial disease activates transcripts of the unfolded protein response and cell cycle and inhibits vesicular secretion and oligodendrocyte-specific transcripts.

Authors:  Gino Cortopassi; Steven Danielson; Mansour Alemi; Shan Shan Zhan; Warren Tong; Valerio Carelli; Andrea Martinuzzi; Sangot Marzuki; Kari Majamaa; Alice Wong
Journal:  Mitochondrion       Date:  2006-05-24       Impact factor: 4.160

View more
  45 in total

1.  Defects in mitochondrial axonal transport and membrane potential without increased reactive oxygen species production in a Drosophila model of Friedreich ataxia.

Authors:  Yujiro Shidara; Peter J Hollenbeck
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

2.  Frataxin depletion in yeast triggers up-regulation of iron transport systems before affecting iron-sulfur enzyme activities.

Authors:  Armando Moreno-Cermeño; Elia Obis; Gemma Bellí; Elisa Cabiscol; Joaquim Ros; Jordi Tamarit
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

3.  Variations of frataxin protein levels in normal individuals.

Authors:  Therese Boehm; Barbara Scheiber-Mojdehkar; Britta Kluge; Hans Goldenberg; Franco Laccone; Brigitte Sturm
Journal:  Neurol Sci       Date:  2010-05-27       Impact factor: 3.307

4.  Structural characterization of metal binding to a cold-adapted frataxin.

Authors:  Martín E Noguera; Ernesto A Roman; Juan B Rigal; Alexandra Cousido-Siah; André Mitschler; Alberto Podjarny; Javier Santos
Journal:  J Biol Inorg Chem       Date:  2015-04-02       Impact factor: 3.358

Review 5.  Advancements in the pathophysiology of Friedreich's Ataxia and new prospects for treatments.

Authors:  Ngolela E Babady; Nadege Carelle; Robert D Wells; Tracey A Rouault; Michio Hirano; David R Lynch; Martin B Delatycki; Robert B Wilson; Grazia Isaya; Hélène Puccio
Journal:  Mol Genet Metab       Date:  2007-06-26       Impact factor: 4.797

6.  Prenatal iron deficiency and monoamine oxidase A (MAOA) polymorphisms: combined risk for later cognitive performance in rhesus monkeys.

Authors:  Mari Golub; Casey Hogrefe
Journal:  Genes Nutr       Date:  2014-01-09       Impact factor: 5.523

Review 7.  Oxidative stress in inherited mitochondrial diseases.

Authors:  Genki Hayashi; Gino Cortopassi
Journal:  Free Radic Biol Med       Date:  2015-06-12       Impact factor: 7.376

8.  Limitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screen.

Authors:  Nadège Calmels; Hervé Seznec; Pascal Villa; Laurence Reutenauer; Marcel Hibert; Jacques Haiech; Pierre Rustin; Michel Koenig; Hélène Puccio
Journal:  BMC Neurol       Date:  2009-08-24       Impact factor: 2.474

9.  The first cellular models based on frataxin missense mutations that reproduce spontaneously the defects associated with Friedreich ataxia.

Authors:  Nadège Calmels; Stéphane Schmucker; Marie Wattenhofer-Donzé; Alain Martelli; Nadège Vaucamps; Laurence Reutenauer; Nadia Messaddeq; Cécile Bouton; Michel Koenig; Hélène Puccio
Journal:  PLoS One       Date:  2009-07-24       Impact factor: 3.240

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.